Distinguishing Multisystem Inflammatory Syndrome in Children From Typhus Using Artificial Intelligence: MIS-C Versus Endemic Typhus (AI-MET) - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing Artificial Intelligence to Differentiate Between Multisystem Inflammatory Syndrome in Children and Endemic Typhus: A Comparative Study of MIS-C and Typhus (AI-MET)

  • By

  • Angela Chun

  • Abraham Bautista-Castillo

  • Isabella Osuna

  • Kristiana Nasto

  • Flor M Munoz

  • Gordon E Schutze

  • Sridevi Devaraj

  • Eyal Muscal

  • Marietta M de Guzman

  • Kristen Sexson Tejtel

  • Tiphanie P Vogel

  • Ioannis A Kakadiaris

  • January 7, 2025

Share

  • 1

    Artificial intelligence was utilized to develop AI-MET, a clinical decision support system distinguishing MIS-C from endemic typhus.

  • 2

    AI-MET achieved 100% accuracy in classifying MIS-C and typhus using 30 clinical and laboratory features from patient data.

  • 3

    A validation cohort demonstrated 99% accuracy in classifying additional MIS-C patients, confirming AI-MET's reliability.

  • 4

    The study highlights the diagnostic challenges posed by the clinical overlap between MIS-C and endemic typhus in febrile children.

  • 5

    Early recognition and treatment of MIS-C and typhus are critical, as they require different therapeutic approaches for optimal outcomes.

Original Source(s)

Distinguishing Multisystem Inflammatory Syndrome in Children From Typhus Using Artificial Intelligence: MIS-C Versus Endemic Typhus (AI-MET)

  • by Angela Chun, Abraham Bautista-Castillo, Isabella Osuna, Kristiana Nasto, Flor M Munoz, Gordon E Schutze, Sridevi Devaraj, Eyal Muscal, Marietta M de Guzman, Kristen Sexson Tejtel, Tiphanie P Vogel, Ioannis A Kakadiaris

  • January 7, 2025

Related Content

Sexual Orientation and Gender Identity Data and HIV Preexposure Prophylaxis Disparity Detection

Errors in Figures, Table, and Supplement

  • October 16, 2026

Impact of direct-to-consumer telemedicine consultations on follow-up consultations, episode costs, and antibiotic prescribing for upper respiratory tract infections in Sweden: An observational study